«Fatal Outcome

Below is an extended Fatal Outcome patents listing. Click here to return to the Fatal Outcome main in depth entry.

Patents :
US Patent No.	Title
6855736	Molecular target of neurotoxicity
7041458	Methods and reagents for determining protein S
7053077	Use of biogenic estrogen sulfamates for hormone replacement therapy
7074911	Endogenous granzyme B in non-immune cells
7094398	Recombinant adenoviral vectors expressing chimeric fiber proteins for cell specific infection and genome integration
7094598	Development of a preventive vaccine for filovirus infection in primates
7101978	TNF-.alpha. binding molecules
7109354	Thiophene amidines, compositions thereof, and methods of treating complement-mediated diseases and conditions
7147848	Recombinant poliovirus for the treatment of cancer
7175679	Oligopeptide treatment of NF-.kappa.B mediated inflammation
7186810	Modified peptides as therapeutic agents
7041302	Therapeutic modulation of the tumor inflammatory response
7026346	Compounds and methods for inducing apoptosis in proliferating cells
7005257	Detection of antibiotic resistance in microorganisms
6884417	Monoclonal antibodies immunoreactive with lipopolysaccharide binding protein (LBP) and methods of their use
6916626	Detection of Candida
6933300	JAK-3 inhibitors for treating allergic disorders
6951925	Processes and agents for detecting Listerias
6967082	Monoclonal antibody
6979316	Apparatus and method for rapid auto-injection of medication
6984387	Immunogenic peptides of foot-and-mouth disease viruses
6989147	Truncated soluble tumor necrosis factor type-I and type-II receptors
6989270	Using polyamide nucleic acid oligomers to engender a biological response
6998122	Protein C derivatives
7199152	TNF-.alpha. production inhibitor comprising kavalactone as an active ingredient
7217802	Method and kit for detecting, or determining, 3,4-methylenedioxymethamphetamine
7361459	Antiviral inhibition of capsid proteins
7370021	Medical applications of adaptive learning systems using gene expression data
7371736	Gene expression profiling based identification of DKK1 as a potential therapeutic targets for controlling bone loss
7390619	Optimization of immunomodulatory properties of genetic vaccines
7392140	Cellular fibronectin as a diagnostic marker in stroke and methods of use thereof
7402431	T-cell therapy formulation
7416741	Copper lowering treatment of inflammatory and fibrotic diseases
7419816	Attenuated rabies virus with nucleoprotein mutation at the phosphorylation site for vaccination against rabies and gene therapy in the CNS
7429238	Systems and methods for the generation of crystalline polymorphs
7435592	Compositions for allogeneic cell therapy
7358330	Immunoregulatory compositions
7351427	Pharmaceutical composition, a method of preparing it and a method of treatment by use thereof
7348401	Peptides that inhibit complement activation
7238776	TNF binding proteins
7258120	Endotracheal tube apparatus and method for using the same to reduce the risk of infections
7258667	Computerized system and method for predicting morality risk using a Lyapunov stability classifier
7262011	Screening of a novel hepatic syndrome and its uses
7264944	TNF receptors, TNF binding proteins and DNAs coding for them
7270818	Pharmaceutically active agents that impede the formation of amyloid by impeding the genesis or growth of DMS
7282483	Method of ameliorating the harmful effects of TNF using a polypeptide having the ability to bind to TNF
7308364	Diagnosis of multiple myeloma on gene expression profiling
7317951	Anchor for medical implant placement and method of manufacture
7344853	Methods for diagnosis and monitoring of neurological disease by detection of an encephalotoxin
7435799	TNF-.alpha. binding molecules

All rights reserved. All other trademarks recognized.
Copyright 1997-2008 - BioPortfolio Limited.